Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
31 hedge funds and large institutions have $12.4M invested in Biolase, Inc. in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
3% less funds holding
Funds holding: 32 → 31 (-1)
16% less capital invested
Capital invested by funds: $14.8M → $12.4M (-$2.41M)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.09M |
| 2 |
State Street
Boston,
Massachusetts
|
+$392K |
| 3 |
VF
Virtu Financial
New York
|
+$163K |
| 4 |
Two Sigma Investments
New York
|
+$81.7K |
| 5 |
Goldman Sachs
New York
|
+$52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$549K |
| 2 |
BlackRock
New York
|
-$425K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$273K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$271K |
| 5 |
Millennium Management
New York
|
-$130K |
BIOL Hedge Fund Activity: Q2 2021 in Review
31 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2021, worth a combined $12.4M — down 16% from $14.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BIOL and 5 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 5 added.
The largest buyer was Perkins Capital Management, adding an estimated $1.09M. The largest seller was Renaissance Technologies, cutting an estimated $549K.
- 31 institutional investors held Biolase, Inc. (BIOL) as of Q2 2021, down from 32 in Q1 2021.
- Funds reported $12.4M of Biolase, Inc. stock for Q2 2021, down 16% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q2 2021 and 6 closed out, a net change of -1 holder.
- The largest Biolase, Inc. buyer in Q2 2021 was Perkins Capital Management, an estimated $1.09M added.
- The largest Biolase, Inc. seller in Q2 2021 was Renaissance Technologies, an estimated $549K sold.
Based on aggregated 13F filings for Q2 2021.